[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"law-eurlex-reg_2010_1141-de":3},{"abbreviation":4,"title":5,"source_type":6,"total":7,"offset":8,"entries":9},"reg_2010_1141","zur Festlegung des Verfahrens für die erneute Aufnahme einer zweiten Gruppe von Wirkstoffen in Anhang I der Richtlinie 91\u002F414\u002FEWG des Rates und zur Erstellung der Liste dieser Wirkstoffe","eurlex",39,0,[10,15,18,21,24,27,30,33,36,39,42,45,48,51,54,58,62,66,70,74,78,82,86,90,94,98,102,106,110,114,118,122,126,130,134,138,143,146,149],{"norm_key":11,"title":12,"chapter":13,"slug":14},"ErwGr. 1",null,"Erwägungsgründe","erwgr-1",{"norm_key":16,"title":12,"chapter":13,"slug":17},"ErwGr. 2","erwgr-2",{"norm_key":19,"title":12,"chapter":13,"slug":20},"ErwGr. 3","erwgr-3",{"norm_key":22,"title":12,"chapter":13,"slug":23},"ErwGr. 4","erwgr-4",{"norm_key":25,"title":12,"chapter":13,"slug":26},"ErwGr. 5","erwgr-5",{"norm_key":28,"title":12,"chapter":13,"slug":29},"ErwGr. 6","erwgr-6",{"norm_key":31,"title":12,"chapter":13,"slug":32},"ErwGr. 7","erwgr-7",{"norm_key":34,"title":12,"chapter":13,"slug":35},"ErwGr. 8","erwgr-8",{"norm_key":37,"title":12,"chapter":13,"slug":38},"ErwGr. 9","erwgr-9",{"norm_key":40,"title":12,"chapter":13,"slug":41},"ErwGr. 10","erwgr-10",{"norm_key":43,"title":12,"chapter":13,"slug":44},"ErwGr. 11","erwgr-11",{"norm_key":46,"title":12,"chapter":13,"slug":47},"ErwGr. 12","erwgr-12",{"norm_key":49,"title":12,"chapter":13,"slug":50},"ErwGr. 13","erwgr-13",{"norm_key":52,"title":12,"chapter":13,"slug":53},"ErwGr. 14","erwgr-14",{"norm_key":55,"title":56,"chapter":12,"slug":57},"Art. 1","Anwendungsbereich","art-1",{"norm_key":59,"title":60,"chapter":12,"slug":61},"Art. 2","Begriffsbestimmungen","art-2",{"norm_key":63,"title":64,"chapter":12,"slug":65},"Art. 3","Koordinierende Behörden in den Mitgliedstaaten","art-3",{"norm_key":67,"title":68,"chapter":12,"slug":69},"Art. 4","Antragstellung","art-4",{"norm_key":71,"title":72,"chapter":12,"slug":73},"Art. 5","Form und Inhalt des Antrags","art-5",{"norm_key":75,"title":76,"chapter":12,"slug":77},"Art. 6","Prüfung des Antrags","art-6",{"norm_key":79,"title":80,"chapter":12,"slug":81},"Art. 7","Vorherige Kontaktaufnahme","art-7",{"norm_key":83,"title":84,"chapter":12,"slug":85},"Art. 8","Zugang zum Antrag","art-8",{"norm_key":87,"title":88,"chapter":12,"slug":89},"Art. 9","Einreichung der ergänzenden Unterlagen","art-9",{"norm_key":91,"title":92,"chapter":12,"slug":93},"Art. 10","Inhalt der ergänzenden Unterlagen","art-10",{"norm_key":95,"title":96,"chapter":12,"slug":97},"Art. 11","Prüfung der ergänzenden Unterlagen","art-11",{"norm_key":99,"title":100,"chapter":12,"slug":101},"Art. 12","Rücknahme des Antrags und Wechsel des Antragstellers","art-12",{"norm_key":103,"title":104,"chapter":12,"slug":105},"Art. 13","Von Dritten übermittelte Informationen","art-13",{"norm_key":107,"title":108,"chapter":12,"slug":109},"Art. 14","Bewertung durch den berichterstattenden und den berichtmiterstattenden Mitgliedstaat","art-14",{"norm_key":111,"title":112,"chapter":12,"slug":113},"Art. 15","Stellungnahmen zum Bewertungsbericht im Hinblick auf die erneute Aufnahme und Zugang zu diesem Bericht und zu der Kurzfassung der ergänzenden Unterlagen","art-15",{"norm_key":115,"title":116,"chapter":12,"slug":117},"Art. 16","Beurteilung des Bewertungsberichts im Hinblick auf die erneute Aufnahme","art-16",{"norm_key":119,"title":120,"chapter":12,"slug":121},"Art. 17","Beurteilungsbericht und Vorlage von Entwürfen von Rechtsakten","art-17",{"norm_key":123,"title":124,"chapter":12,"slug":125},"Art. 18","Zugang zum Beurteilungsbericht","art-18",{"norm_key":127,"title":128,"chapter":12,"slug":129},"Art. 19","Gebühren und Abgaben","art-19",{"norm_key":131,"title":132,"chapter":12,"slug":133},"Art. 20","Andere Entgelte, Abgaben oder Gebühren","art-20",{"norm_key":135,"title":136,"chapter":12,"slug":137},"Art. 21","Inkrafttreten","art-21",{"norm_key":139,"title":140,"chapter":141,"slug":142},"Anhang I","Liste der in Artikel 1 genannten Wirkstoffe mit den entsprechenden berichterstattenden Mitgliedstaaten („BMS“) und berichtmiterstattenden Mitgliedstaaten („BMMS“) sowie dem letztmöglichen Tag für die Einreichung der Unterlagen","Anhänge","anhang-i",{"norm_key":144,"title":145,"chapter":141,"slug":12},"Anhang II.1","Form des Antrags gemäß Artikel 5 Absatz 1",{"norm_key":147,"title":148,"chapter":141,"slug":12},"Anhang II.2","1. Angaben zum Antragsteller",{"norm_key":150,"title":151,"chapter":141,"slug":12},"Anhang II.3","2. Angaben zur Erleichterung der Identifizierung des Wirkstoffs"]